Diabetes Mellitus, Type 2 Clinical Trial
Official title:
The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence
The proposed study is a pilot study to gather data on the effectiveness and feasibility of a software tool (EMPATHy) to help patients communicate effectively with doctors about problems they face with their medication regimens. EMPATHy will be incorporated into an existing clinic-based intervention called Coached Care, in which community health workers (CHWs, non-professional community members) work as a "Coach" to patients to help them improve engagement and communication during the medical visit.
Low income, Mexican American patients with diabetes exhibit high rates of medication
nonadherence, which results in poor blood sugar control and serious complications, and often
have difficulty communicating their concerns about the medication regimen to physicians.
Interventions led by community health workers (CHWs), non-professional community members who
are trained to work with patients to improve engagement and communication during the medical
visit, have had mixed success in improving outcomes. Although CHWs possess excellent
cultural competency and are very effective at establishing rapport with patients, they often
lack a sophisticated understanding of all the potential challenges that can come with
following a regimen. The primary objective of this project is to develop and pilot test a
prototype software toolkit called "EMPATHy" that a CHW can administer to help patients
identify and articulate the most important barriers to adherence that they face.
The EMPATHy toolkit will be piloted in an ongoing intervention (Coached Care) in which CHWs
are trained to be "Coaches" to meet with patients before the medical visit, and help them
prepare a list of important questions for the doctor. The Lead Researcher (Billimek) is a
co-director of this intervention program at UCI's Ambulatory Clinics, including the Family
Health Center in Santa Ana ,with a highly vulnerable population—low income Mexican American
patients with diabetes and a history of nonadherence. A CHW will be trained to use two
commercially available software programs configured by the PI to deliver the intervention
materials. Patients participating in Coached Care (which is a clinic- based intervention,
not a research protocol) will be recruited to (1) complete a Coached Care intervention
session that has been modified to incorporate the EMPATHy Toolkit, (2) answer questions
about barriers to medication adherence and the feasibility/usability of the software (3)
allow the research team to abstract data on the medication regimen and diabetes outcomes
(hemoglobin A1c, LDL cholesterol, etc) from the patient's medical record.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |